Lol some of the members that post here claim that they have hundreds of thousands invested here not knowing anything. And all insiders only put up 217k knowing everything. Wow shows confidence . If i had inside knowlege of multi bilion dollar opurtunity just year-2 away and having oppurtinity to accually buy large chunk .Yet they DIDN'T? Propably used spare couch change like u guys did lol

They put in like 10k each on something that supposed to be worth billions. Shows confidence since they know what is really going on on the inside. Yea ok:( and only 7 mil? No onterest?

Lets go SOUL

Dont see any dumping. Lol only upside

Lets hit those 4's

Lol

U can use unsettelled funds to buy stock. Scottrade

I dont always wanna come off negative . I was propably one of the first investors in Titan. Made out great when stock went from low .30s to $2.50 in short period of time. Was also in and out of titan since than . But now with this financing they are about to double if not triple the float including warrants if they raise 17mil at this level. If they did not show any kind of support. At least saying they will buy. ( Who knows anyway) people would dump and they would propably have to stop operations and halt sport. So sure at least they using some kind of lipstick on this pig. Hey i still want to belive that this is real but didnt ximedica had sport finished some time ago. And also seeing fowler go was a huge turn off for me. It was pretty much his invention. And just to leave. I dont know anymore. 11out

R/s will have the same effect on price to excercise those warrants. Seems like nobody is sure about anything on this board. Do your research how r/s will affect os warrants and options.

The company doesnt care about current retail investors. They care about who funds next pp. They get taken care off. They cant loose money. Retail can. Once they dump all the shares r/s comes. New investors will come thinking this is the best opportunity investing this early in the game. Rinse and repeat. YEA RIGHT. Ill wait to see product hit the market and than ill think about it. Been around the block once or twice. Dream big boys.

If they raise full 17 mil at .13cents how many shares will they have to sell? :( + double that # for warrants.

I am a buyer at
.10 after 1/50 rs. Ill wait.

Lets go soul

What news should we expect here? Tia

So di anybody try to reach out to the company and got any kind of reply. What would e some short term news here. Tia

U missunderstanded my thought. Simply if fitst patient gets treated with low dose((((((( hurray we got one)))))) and after 30 days they still see some signs of cancer is the same patient allowed to participate in regular dose treatment? Tia

Just a thought but are the first 3 patient with low dose allowed to also participate in the second six patient group trial. It's hard to convince someone that is on a verge of loosing a bladder that it is only a safety trial of low dose and most likely cancer won't be defeated. In that case patient might wait for the full dose and won't participate in low dose. If that is the case. Those patients want to try to beat the cancer. Right? Those patients been trough hell . They should be allowed to participate in low dose and if all good than 30 days later with full dose so hopefully they can save their bladder. Imo

Korelin interview next week. Forward your questions. Was told lots going on. He Can't share anything before goes public. Sounded like news is imitent. Before when I called in January)he straigh up told me no patients were enrolled. This time he says he can't discuss anything in that nature. To me it sound like maybe patients are enrolled and being treated and can't discuss with single investor before pr is out. Maybe:)

Just talked with RW. Will update soon. Driving.

Waited 2 years to see this trough. Almost there to see if it is safe and if it works in humans. Waiting patiently.

Spoke to Roger this morning. No one has been treated yet. Lots of paperwork before it can actually hapen. It is imitent. Can be any day now. It's is completely up to princess Margaret now. Cheers

This could be the ONE that will find a cure or at least a good treatment .

Let's spread the word about this company .

Will Rayman be dumping his shares or holding ? Who here knowso what he owns?

Per agm video first 3 patients get low dose and if ok next 6 patients will get double the dose.

It's more than 1/10 of a dose . I think

Ok
Something is up. :)

Some will take profits. Not everyday use can make 100% in 2 days

So fowler is completely out of the picture now?

I also got burned here pretty bad when trials got halted but tltff will be a winner

Anyboy that is interested look at TLTFF Just started human trials on friday. Could be huge.

Let the trials begin :)

Toronto, Ontario - December 9, 2016, Theralase Technologies Inc. ("Theralase®" or the "Company") (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds ("PDCs") to destroy cancer, announced today that it has commenced a Phase Ib clinical study indicated for the treatment of Non-Muscle Invasive Bladder Cancer ("NMIBC").
The design of the clinical study allows for the initial enrollment of three participants to be treated at a low dose using the light activated PDC, TLD-1433. These three participants will be monitored for thirty days and if the treatment is safe and tolerable, then an additional group of 6 participants will be enrolled at a higher dose and monitored for six months.
The Phase Ib NMIBC clinical trial will evaluate TLD-1433, activated by the TLC-3200 medical laser system in conjunction with the TLC-3400 Dosimetry Fibre Optic Cage, for the primary endpoints of safety and tolerability, with a secondary endpoint of pharmacokinetics (movement of drug in tissue) and an exploratory endpoint of efficacy.
If the Theralase treatment is safe and tolerable, then a Phase II clinical study will be commenced in Canada, the United States and Europe with a primary outcome measure of efficacy.
Arkady Mandel, MD, PhD, DSc, Chief Scientific Officer of Theralase stated that, "The scientific and pre-clinical data to date has been strongly supportive of commencing a Phase Ib NMIBC clinical study. I look forward to commencing the NMIBC clinical study to investigate whether the successes of this technology preclinically can be translated to a clinical population."
Roger Dumoulin-White, President and CEO of Theralase stated that, "I am pleased that the Phase Ib clinical study has been allowed to commence and we are able to begin enrolling participants. The screening process takes approximately 2 weeks, so the first patient treated should occur late this year or early next year. I look forward to demonstrating to the medical community what the Theralase PDC anti-cancer technology is capable of."
About Theralase Technologies Inc.
Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (TLTFF: OTC) in its Therapeutic Laser Technology division designs, manufactures, markets and distributes patented super-pulsed laser technology indicated for the treatment of chronic knee pain and in off-label use the elimination of pain, reduction of inflammation and acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase's Photo Dynamic Therapy division researches and develops specially designed molecules called Photo Dynamic Compounds, which localize to cancer cells and then when laser light activated, effectively destroy them.

Read more at http://www.stockhouse.com/companies/bullboard/tltff/theralase-technologies-inc#e177sk7mcP4x6OCI.99

TLT Demonstrates 12 Month Stability of Lead Anti-Cancer Drug
Toronto, Ontario - November 30, 2016, Theralase Technologies Inc. ("Theralase®" or the "Company") (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds ("PDCs") to destroy cancer, announced today that it has demonstrated 12 month long term stability of it lead anti-cancer Photo Dynamic Compound ("PDC"), TLD-1433.
Stability studies are an essential component of pharmaceutical development, allowing evaluation of a drug's stability under the influence of a variety of environmental factors such as: temperature, humidity and light.
Data from these studies enable recommended storage conditions, retest intervals and shelf lives to be established. Demonstrating long term stability of a drug to be used in human clinical testing is essential to prove that the potency and/or efficacy of the drug is not affected during prolonged shelf life.
Under long term and accelerated stability storage conditions, the drug is evaluated by High Performance Liquid Chromatography ("HPLC") to separate, identify and quantify each chemical component to a very high degree of resolution to assess if any changes occur in the chemical composition over time.
Long term stability is completed over three years, with reporting at 0, 3, 6, 9, 12, 18, 24 and 36 months.
Accelerated stability is completed over six months, with reporting at 0, 3 and 6 months.
6 month accelerated stability and 12 month long term stability testing have now been successfully completed.
TLD-1433 has now demonstrated that it has remained stable at these reported time periods and according to Health Canada guidelines, long term and accelerated stability has now been proven at 6 months accelerated and 12 month long term, allowing use in treating patients in a clinical study.
Theralase is focused on commencing and successfully completing a Phase Ib clinical trial for patients afflicted with Non-Muscle Invasive Bladder Cancer ("NMIBC") utilizing its novel next generation light-activated, anti-cancer drug, TLD-1433.
The Phase Ib NMIBC clinical trial will evaluate TLD-1433 for the primary endpoints of safety and tolerability, with a secondary endpoint of pharmacokinetics (movement and exit of drug within tissue) and an exploratory endpoint of efficacy.

Read more at http://www.stockhouse.com/companies/bullboard/tltff/theralase-technologies-inc#ul9k1SQSGKkDMIJL.99

There should be korelin report due out soon with one of theralase-technologies-inc doctors. I will post link if it happens today.

Called company today. Rw is on business trip. Once in a while i like to call the company and see what i can find out. I will call again Monday. Approval is here money is here so lets get going with these trials already. We should be registered to for the trial. And patients are selected as we speak. (Hopefully) Lets go waited 2 long years for this. Even tho my account took a hit this sp might fly on speculation of the trials.

Are u new to tltff. Whats your personal opinion here. I read your posts on mj stocks. I am in couple of them. Shipping sector also hot. Tia spread the word about potential cancer cure.!!!!

What is your opinion on the latest pp and 60 month warrants. Will this kill the upside when some good news is released?

What u think cuin. We move up from here . Finally we enter the human trials. Should be lots of speculation. ?